Blaine McKee is the founder of Walden Biosciences. Walden Biosciences has raised $51M in total funding. Latest round: Series A. Based in Cambridge, USA.
Blaine McKee, Ph.D., is the President and Chief Executive Officer of Walden Biosciences, a venture-backed biopharmaceutical/biotechnology company in Cambridge, Massachusetts, focused on renal disease. He has led the company since January 2020 and established its facility in Kendall Square.
Full founder directory · Investor directory · Company funding database · Fundraising library